trending Market Intelligence /marketintelligence/en/news-insights/trending/wgzQb4RcMqvCjkqCo2S_Kw2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Medovex, Technology Consult partner to sell Denervex system in Germany

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Medovex, Technology Consult partner to sell Denervex system in Germany

Medovex Corp. entered into a partnership with Technology Consult Berlin GmbH for distribution of its Denervex system in Germany.

Technology Consult is expected to provide sales, marketing and distribution services.

On March 13, the company said the reimbursement authority in Germany had renewed reimbursement payment coding for its Denervex system technology for the treatment of the facet joint syndrome for 2017.

The coding was released in the diagnosis-related group system in 2017 in Germany and allows for hospitals and outpatient centers to receive reimbursement for the use of the system.

Denervex is not yet commercially available in the EU and the U.S. The system is not yet FDA cleared.